Orchestra BioMed Holdings Inc. Income Statement
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
2023
2022
2021
2020
3M
-21.88%
0M
3M
54M
20M
34M
-52M
0M
-49M
0M
-49M
1,695.90%
0M
4M
0M
0M
0M
4M
-551.79%
0M
3M
3M
14M
22M
-3M
0M
-3M
0M
-3M
-88.12%
3M
0M
-3M
0M
-3M
-1M
-113.71%
0M
-1M
21M
8M
13M
-22M
1M
-23M
0M
-23M
7.77%
21M
-1M
-22M
0M
-22M
6M
-
0M
6M
24M
11M
13M
-19M
0M
-21M
0M
-21M
7.77%
24M
0M
-16M
0M
-16M
Concept
Total Revenue
YoY
Cost of Goods Sold (COGS)
Gross Profit
Operating expenses
Selling, General & Administrative
Research & Development
Operating Income
Interest Expense
Income Before Tax
Tax Provision
Net Income
YoY
Total Expenses
Net Interest Income
EBITDA
Reconciled Depreciation
EBIT
4Q2023
3Q2023
2Q2023
1Q2023
4Q2022
3Q2022
2Q2022
1Q2022
0M
-76.25%
0M
0M
13M
4M
9M
-12M
0M
-13M
0M
-13M
1,362.04%
0M
1M
0M
0M
0M
0M
-63.97%
0M
0M
15M
6M
9M
-15M
0M
-13M
0M
-13M
1,841.70%
15M
1M
-15M
0M
-15M
1M
128.18%
0M
1M
14M
5M
8M
-13M
0M
-12M
0M
-12M
53.51%
14M
1M
-13M
0M
-13M
1M
34.41%
0M
1M
13M
4M
8M
-12M
0M
-11M
0M
-11M
90.96%
13M
1M
-11M
0M
-11M
1M
-
0M
1M
1M
3M
8M
-1M
0M
-1M
0M
-1M
90.96%
1M
0M
-1M
0M
-1M
1M
-
0M
1M
1M
5M
6M
-1M
0M
-1M
0M
-1M
90.96%
1M
0M
-1M
0M
-1M
0M
-
0M
0M
8M
3M
5M
-8M
0M
-8M
0M
-8M
90.96%
8M
0M
-8M
0M
-8M
1M
-
0M
1M
6M
2M
3M
-5M
0M
-6M
0M
-6M
90.96%
6M
0M
-5M
0M
-5M